FDA Inspection 1071303 — Omega Biological Laboratories Inc.

Omega Biological Laboratories Inc. — FEI 3002864704

The FDA completed an inspection of Omega Biological Laboratories Inc. on November 7, 2018 in Lyndhurst, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 7, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lyndhurst, NJ (United States)

Citations

IDCFRDescription
188521 CFR 211.165(b)Microbiological testing
240121 CFR 211.194(a)(4)Complete Test Data